Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione | Patent Publication Number 20040029832

US 20040029832 A1
Patent NumberUS 07968569 B2
Application Number10438213
Filled DateMay 15, 2003
Priority DateMay 17, 2002
Publication DateFeb 12, 2004
Original AssigneeBristol Myers Squibb
Current AssigneeCelgene
Inventor/ApplicantsJerome B. Zeldis
Jerome B. Zeldis
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.